LGR5+ Intestinal Stem Cells Display Sex Dependent Radiosensitivity.
Ryan C ZitterRishi Man ChughPayel BhanjaSubhrajit SahaPublished in: bioRxiv : the preprint server for biology (2023)
Radiosensitivity, the susceptibility of cells to ionizing radiation, plays a critical role in understanding the effects of radiation therapy and exposure on tissue health and regeneration. Identifying characteristics that predict how a patient may respond to radiotherapy enables clinicians to maximize the therapeutic window. Limited clinical data suggested a difference in male and female radiotherapy outcomes. Radiotherapy for gastrointestinal malignancy is still a challenge due to intestinal sensitivity to radiation toxicity. In this manuscript, we demonstrated sex-specific differences in intestinal epithelial radiosensitivity. In mice models of abdominal irradiation, we observed a significant increase in oxidative stress and injury in males compared to females. Lgr5+ve intestinal stem cells from male mice showed higher sensitivity to radiation-induced toxicity. However, sex-specific differences in intestinal radiosensitivity are not dependent on sex hormones as we demonstrated similar sex-specific radiosensitivity differences in pediatric mice. In an ex-vivo study, we found that human patient-derived intestinal organoids (PID) derived from males showed higher sensitivity to irradiation compared to females as evidenced by loss of budding crypt, organoid size, and membrane integrity. Transcriptomic analysis of human Lgr5+ intestinal stem cells suggested radiation induced upregulation of mitochondrial oxidative metabolism in males compared to females' possible mechanism for radiosensitivity differences.
Keyphrases
- radiation induced
- radiation therapy
- stem cells
- oxidative stress
- endothelial cells
- early stage
- induced apoptosis
- healthcare
- locally advanced
- skeletal muscle
- type diabetes
- risk assessment
- machine learning
- mental health
- long non coding rna
- young adults
- signaling pathway
- big data
- cell death
- squamous cell carcinoma
- electronic health record
- rna seq
- cell cycle arrest